Journal of Clinical Endocrinology & Metabolism, Vol 68, 352-358, Copyright © 1989 by Endocrine Society

ARTICLES

Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy

RR Grunstein, DJ Handelsman, SJ Lawrence, C Blackwell, ID Caterson and CE Sullivan
Sleep Unit, Royal Prince Alfred Hospital, Sydney, Australia.

We studied the effects of sleep apnea on neuroendocrine function in a cross-sectional study of 225 consecutive men undergoing sleep studies and in a longitudinal study of 43 men with severe obstructive sleep apnea before and after 3 months of successful treatment with nasal continuous positive airways pressure to eliminate upper airways obstruction. Blood samples were collected at 0600-0630 h on awakening for measurement of plasma insulin-like growth factor I (IGF-I), total and free testosterone, sex hormone-binding globulin (SHBG), LH, FSH, PRL, T4, T4-binding globulin, and cortisol. The plasma hormone levels were analyzed in relation to the severity of sleep apnea, as indicated by the desaturation index (the hourly rate of episodes of arterial oxygen desaturation greater than 4% of the stable baseline) and the mean minimal oxygen saturation during the desaturation episodes. In the cross-sectional study plasma IGF-I, free and total testosterone, and SHBG levels were significantly lower in relation to the severity of sleep apnea, whereas plasma LH, FSH, PRL, T4, T4-binding globulin, and cortisol were not. The decreases in plasma IGF-I and total and free testosterone were independent of the effects of aging and adiposity by covariance analysis. In the longitudinal study plasma IGF-I, total testosterone, and SHBG, but not free testosterone, significantly increased after 3 months of nasal continuous positive airways pressure treatment. We conclude that sleep apnea causes reversible neuroendocrine dysfunction in men, which is manifested by decreased plasma. IGF-I, testosterone, and SHBG levels. This neuroendocrine dysfunction is related to the severity of the sleep apnea, as indicated by the nadir levels of arterial oxygen desaturation and the rate of desaturation episodes. These hormonal measurements may provide biochemical markers for both the severity of sleep apnea and its response to therapeutic intervention. In addition, sleep apnea may be a previously unrecognized confounder of the neuroendocrine correlates of aging.

This article has been cited by other articles:

				G. Carneiro, S. M. Togeiro, L. F. Hayashi, F. F. Ribeiro-Filho, A. B. Ribeiro, S. Tufik, and M. T. Zanella Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E380 - E384. [Abstract] [Full Text] [PDF]

				E. Barrett-Connor, T.-T. Dam, K. Stone, S. L. Harrison, S. Redline, E. Orwoll, and for the Osteoporotic Fractures in Men Study Group The Association of Testosterone Levels with Overall Sleep Quality, Sleep Architecture, and Sleep-Disordered Breathing J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2602 - 2609. [Abstract] [Full Text] [PDF]

				A. N. Vgontzas, S. Pejovic, E. Zoumakis, H.-M. Lin, C. M. Bentley, E. O. Bixler, A. Sarrigiannidis, M. Basta, and G. P. Chrousos Hypothalamic-Pituitary-Adrenal Axis Activity in Obese Men with and without Sleep Apnea: Effects of Continuous Positive Airway Pressure Therapy J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4199 - 4207. [Abstract] [Full Text] [PDF]

				F. Dadoun, P. Darmon, V. Achard, S. Boullu-Ciocca, F. Philip-Joet, M. C. Alessi, M. Rey, M. Grino, and A. Dutour Effect of sleep apnea syndrome on the circadian profile of cortisol in obese men Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E466 - E474. [Abstract] [Full Text] [PDF]

				N. McArdle, D. Hillman, L. Beilin, and G. Watts Metabolic Risk Factors for Vascular Disease in Obstructive Sleep Apnea: A Matched Controlled Study Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 190 - 195. [Abstract] [Full Text] [PDF]

				N. M. Punjabi and V. Y. Polotsky Disorders of glucose metabolism in sleep apnea J Appl Physiol, November 1, 2005; 99(5): 1998 - 2007. [Abstract] [Full Text] [PDF]

				J. M. Kaufman and A. Vermeulen The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications Endocr. Rev., October 1, 2005; 26(6): 833 - 876. [Abstract] [Full Text] [PDF]

				F. J. O'Donoghue, R. S. Briellmann, P. D. Rochford, D. F. Abbott, G. S. Pell, C. H. P. Chan, N. Tarquinio, G. D. Jackson, and R. J. Pierce Cerebral Structural Changes in Severe Obstructive Sleep Apnea Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1185 - 1190. [Abstract] [Full Text] [PDF]

				T. M. Buckley and A. F. Schatzberg On the Interactions of the Hypothalamic-Pituitary-Adrenal (HPA) Axis and Sleep: Normal HPA Axis Activity and Circadian Rhythm, Exemplary Sleep Disorders J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3106 - 3114. [Abstract] [Full Text] [PDF]

				A. Morton Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1903 - 1903. [Full Text] [PDF]

				K. M. Oltmanns, H. Gehring, S. Rudolf, B. Schultes, S. Rook, U. Schweiger, J. Born, H. L. Fehm, and A. Peters Hypoxia Causes Glucose Intolerance in Humans Am. J. Respir. Crit. Care Med., June 1, 2004; 169(11): 1231 - 1237. [Abstract] [Full Text] [PDF]

				A. Morton Hormones and the heart -- is sleep apnoea the link? Eur. Heart J., February 1, 2004; 25(3): 278 - 279. [Full Text] [PDF]

				T. Saaresranta and O. Polo Sleep-disordered breathing and hormones Eur. Respir. J., July 1, 2003; 22(1): 161 - 172. [Abstract] [Full Text] [PDF]

				T. Saaresranta and O. Polo Hormones and Breathing Chest, December 1, 2002; 122(6): 2165 - 2182. [Abstract] [Full Text] [PDF]

				L. Gianotti, S. Pivetti, F. Lanfranco, F. Tassone, F. Navone, E. Vittori, R. Rossetto, C. Gauna, S. Destefanis, S. Grottoli, et al. Concomitant Impairment of Growth Hormone Secretion and Peripheral Sensitivity in Obese Patients with Obstructive Sleep Apnea Syndrome J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5052 - 5057. [Abstract] [Full Text] [PDF]

				R. Luboshitzky, A. Aviv, A. Hefetz, P. Herer, Z. Shen-Orr, L. Lavie, and P. Lavie Decreased Pituitary-Gonadal Secretion in Men with Obstructive Sleep Apnea J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3394 - 3398. [Abstract] [Full Text] [PDF]

				W. K. Al-Delaimy, J. E. Manson, W. C. Willett, M. J. Stampfer, and F. B. Hu Snoring as a Risk Factor for Type II Diabetes Mellitus: A Prospective Study Am. J. Epidemiol., March 1, 2002; 155(5): 387 - 393. [Abstract] [Full Text] [PDF]

				A. M. Matsumoto Andropause: Clinical Implications of the Decline in Serum Testosterone Levels With Aging in Men J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2002; 57(2): M76 - 99. [Full Text]

				L. P. Ly, M. Jimenez, T. N. Zhuang, D. S. Celermajer, A. J. Conway, and D. J. Handelsman A Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Transdermal Dihydrotestosterone Gel on Muscular Strength, Mobility, and Quality of Life in Older Men with Partial Androgen Deficiency J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4078 - 4088. [Abstract] [Full Text] [PDF]

				R. B. Fogel, A. Malhotra, G. Pillar, S. D. Pittman, A. Dunaif, and D. P. White Increased Prevalence of Obstructive Sleep Apnea Syndrome in Obese Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1175 - 1180. [Abstract] [Full Text]

				J. A. Loadsman and D. R. Hillman Anaesthesia and sleep apnoea Br. J. Anaesth., February 1, 2001; 86(2): 254 - 266. [Abstract] [Full Text] [PDF]

				C.F. Ryan, A.A. Lowe, and J.A. Fleetham Nasal Continuous Positive Airway Pressure (CPAP) Therapy: For Obstructive Sleep Apnea in Hallermann-Streiff Syndrome Clinical Pediatrics, February 1, 1990; 29(2): 122 - 124. [Abstract] [PDF]